Suicide Paxil 25/09/2006 California Teen-Age Girl Commits Suicide Summary:

Paragraph 1 and first part of paragraph 2 read:  "Kit and Dave Miller wanted people to know that Molly's suicide was prescription-drug related. In September, Molly was prescribed the anti-depressant Paxil. Two weeks later the dosage was increased. They all thought she was happier than before, and she had made plans for the holidays and was engaged in her schoolwork. Her choice to take her life was a complete shock."

"Since then, Kit and Dave Miller have found out how common this experience actually is, of teens on anti-depressants taking their own lives."

        
http://www.baynvc.org/new_announcement_details.php?announcement_id=114

Update from Kit and Dave

November 28, 2006

Kit and Dave Miller feel deep gratitude for the support that has flowed their way. They continue to reach deeply into their spiritual practices to sustain them.

Kit and Dave Miller wanted people to know that Molly's suicide was prescription-drug related. In September, Molly was prescribed the anti-depressant Paxil. Two weeks later the dosage was increased. They all thought she was happier than before, and she had made plans for the holidays and was engaged in her schoolwork. Her choice to take her life was a complete shock.

Since then, Kit and Dave have found out how common this experience actually is, of teens on anti-depressants taking their own lives. If you want to read further about this, see http://www.ssristories.drugawareness.org/index.php. Additionally, some other families whose children have either attempted suicide or completed suicide have begun a website, at http://www.participatenow.net . See the related site that features a full length documentary on anti-depressant related suicide among children at http://www.prescriptionsuicide.com .

Kit and Dave have filed a report with MedWatch, the FDA Safety Information and Adverse Event Reporting Program regarding Molly's passing. They will write and share Molly's story in the media and are working with her therapist and primary care physician in doing so.

It is their hope that all of us will gain much more awareness of the risks, benefits, and use of anti-depressants for people under 18 years of age. They want to help all of the stakeholders in improving our healthcare system: regulators, drug companies, pharmacies, doctors, therapists, parents and guardians, and patients.